Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FMOD |
| Upstream (Parents) |
|---|
| (<<) LTBP2 → FMOD |
| (<<) CRISPLD2 → FMOD |
| (<<) PALLD → FMOD |
| (<<) ARMCX1 → FMOD |
| (<<) COL16A1 → FMOD |
| Downstream (Children) |
|---|
| FMOD → FAM75A5///FAM75A3///FAM75A1///FAM75A4///FAM75A2///FAM75A6///FAM75A7 (>>) |
| FMOD → TEX14 (>>) |
| FMOD → PCDHA2 (>>) |
| FMOD → ARHGEF4 (>>) |
| FMOD → NUDT11 (>>) |
| FMOD → EFNB3 (>>) |
| FMOD → EFS (>>) |
| FMOD → IQCA1 (>>) |
| FMOD → ARMCX1 (>>) |
| FMOD → NR2C1 (>>) |
